Showing results (1271-1280 of 2,178) with videos related to

Sort By:
Pageof 218
Neuromolecular Medicine|January 1, 2005
BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorderJ Strauss, C L Barr, C J George, et al.
Journal of Palliative Care|March 12, 2021
Systematic Analysis of Extracting Data on Advance Directives from Patient Electronic Health Records (EHR) in Terminal Oncology PatientsJason S Starr, William Paul Skelton, Kiarash P Rahmanian, et al.
Cureus|December 3, 2021
Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal AdenocarcinomaMahmoud Aryan, Thomas Read, Lindsey Goldstein, et al.
Transplantation|June 27, 1996
Incidence and predictors of cytomegalovirus pneumonia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study GroupM E Falagas, D R Snydman, M J George, et al.
Archives of Physical Medicine and Rehabilitation|April 1, 2015
Factors associated with discharge to home versus discharge to institutional care after inpatient stroke rehabilitationVu Q C Nguyen, Janet PrvuBettger, Tami Guerrier, et al.
Clinical Genitourinary Cancer|February 25, 2015
Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate CancerTian Zhang, Mallika S Dhawan, Patrick Healy, et al.
The Annals of Thoracic Surgery|May 26, 2012
Should orthotopic heart transplantation using marginal donors be limited to higher volume centers?Arman Kilic, Eric S Weiss, Jeremiah G Allen, et al.
Cancer Research|October 17, 2014
Copper signaling axis as a target for prostate cancer therapeuticsRachid Safi, Erik R Nelson, Satish K Chitneni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480D J George, S Halabi, T F Shepard, et al.
Advances in Therapy|March 1, 2020
Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus PrednisoneKrishnan Ramaswamy, Stanislav Lechpammer, Jack Mardekian, et al.
Pageof 218